易狐药讯
Published by:
Logic Solutions Shanghai Co
Description
【易狐药讯】是星辰启联（南京）数字技术有限责任公司旗下开发的网上药品信息交流平台。主要板块有医药招商、政策资讯、视频访谈、信息发布等多个模块；为用户提供最方便的数据查询、产品信息交流、资讯政策浏览等功能。
Screenshots
易狐药讯 FAQ
-
Is 易狐药讯 free?
Yes, 易狐药讯 is completely free and it doesn't have any in-app purchases or subscriptions.
-
Is 易狐药讯 legit?
Not enough reviews to make a reliable assessment. The app needs more user feedback.
Thanks for the vote -
How much does 易狐药讯 cost?
易狐药讯 is free.
-
What is 易狐药讯 revenue?
To get estimated revenue of 易狐药讯 app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.
User Rating
App is not rated in Nigeria yet.
Ratings History
易狐药讯 Reviews
Store Rankings
Ranking History
App Ranking History not available yet
Category Rankings
App is not ranked yet
易狐药讯 Installs
Last 30 days
易狐药讯 Revenue
Last 30 days易狐药讯 Revenue and Downloads
Gain valuable insights into 易狐药讯 performance with our analytics.
Sign up now to access downloads, revenue, and more.
Sign up now to access downloads, revenue, and more.
App Info
- Category
- Utilities
- Publisher
- Logic Solutions Shanghai Co
- Languages
- English
- Recent release
- 1.1.9 (6 months ago )
- Released on
- Mar 25, 2024 (9 months ago )
- Also available in
- New Zealand, Italy, South Korea, Kazakhstan, Lebanon, Mexico, Malaysia, Nigeria, Netherlands, India, Pakistan, Poland, Portugal, Romania, Russia, Sweden, Ukraine, Vietnam, Dominican Republic, Austria, Azerbaijan, Belgium, Belarus, Switzerland, China, Czechia, Germany, Argentina, Algeria, Ecuador, Egypt, United Kingdom, Greece, Indonesia, Ireland, Israel
- Last Updated
- 5 days ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.